Inhibition of the FACT Complex Targets Aberrant Hedgehog Signaling and Overcomes Resistance to Smoothened Antagonists

平滑 刺猬 刺猬信号通路 生物 细胞生物学 信号转导
作者
Jialin Mo,Fang Liu,Xi Sun,Hongting Huang,Kezhe Tan,Xiaojing Zhao,Rui Li,Wenyan Jiang,Yi Sui,Xiaosong Chen,Kunwei Shen,Liye Zhang,Jie Ma,Kewen Zhao,Yujie Tang
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:81 (11): 3105-3120 被引量:16
标识
DOI:10.1158/0008-5472.can-20-3186
摘要

Abstract Hedgehog signaling is aberrantly activated in hematologic malignancies and solid tumors, and targeting it is a promising therapeutic strategy against these cancers. Resistance to clinically available hedgehog-targeted Smoothened inhibitor (SMOi) drugs has become a critical issue in hedgehog-driven cancer treatment. Our previous studies identified inhibition of BET and CDK7 as two epigenetic/transcriptional-targeted therapeutic strategies for overcoming SMOi resistance, providing a promising direction for anti-hedgehog drug development. To uncover additional strategies for inhibiting aberrant hedgehog activity, here we performed CRISPR-Cas9 screening with an single-guide RNA library targeting epigenetic and transcriptional modulators in hedgehog-driven medulloblastoma cells, combined with tumor dataset analyses. Structure specific recognition protein 1 (SSRP1), a subunit of facilitates chromatin transcription (FACT) complex, was identified as a hedgehog-induced essential oncogene and therapeutic target in hedgehog-driven cancer. The FACT inhibitor CBL0137, which has entered clinical trials for cancer, effectively suppressed in vitro and in vivo growth of multiple SMOi-responsive and SMOi-resistant hedgehog-driven cancer models. Mechanistically, CBL0137 exerted anti-hedgehog activity by targeting transcription of GLI1 and GLI2, which are core transcription factors of the hedgehog pathway. SSRP1 bound the promoter regions of GLI1 and GLI2, while CBL0137 treatment substantially disrupted these interactions. Moreover, CBL0137 synergized with BET or CDK7 inhibitors to antagonize aberrant hedgehog pathway and growth of hedgehog-driven cancer models. Taken together, these results identify FACT inhibition as a promising epigenetic/transcriptional-targeted therapeutic strategy for treating hedgehog-driven cancers and overcoming SMOi resistance. Significance: This study identifies FACT inhibition as an anti-hedgehog therapeutic strategy for overcoming resistance to Smoothened inhibitors and provides preclinical support for initiating clinical trials of FACT-targeted drug CBL0137 against hedgehog-driven cancers.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
欣慰忆山完成签到,获得积分10
4秒前
雪山大地发布了新的文献求助10
5秒前
蜗牛完成签到,获得积分10
7秒前
结实新波完成签到,获得积分10
7秒前
8秒前
俏皮飞柏完成签到,获得积分10
8秒前
方方完成签到 ,获得积分10
11秒前
时尚之桃完成签到 ,获得积分10
11秒前
fantasy的应助被369ninja采纳,获得10
13秒前
朴实初夏完成签到 ,获得积分0
14秒前
xiangfan完成签到,获得积分10
14秒前
幸福立果完成签到,获得积分10
15秒前
Auster发布了新的文献求助10
15秒前
穆里完成签到 ,获得积分10
19秒前
dldldl完成签到,获得积分0
20秒前
按时开心完成签到 ,获得积分10
21秒前
ninomae完成签到 ,获得积分10
22秒前
微笑的严青完成签到,获得积分10
23秒前
整齐白秋完成签到 ,获得积分10
23秒前
柒柒大王完成签到,获得积分20
24秒前
雪山大地发布了新的文献求助10
27秒前
aikeyan完成签到,获得积分10
27秒前
28秒前
xiaojinyu195完成签到,获得积分10
29秒前
李木子完成签到,获得积分10
29秒前
fantasy的应助被369ninja采纳,获得10
29秒前
Yolanda_Xu完成签到 ,获得积分10
31秒前
t铁核桃1985完成签到 ,获得积分0
34秒前
maomao完成签到 ,获得积分10
36秒前
tyuuoooo完成签到 ,获得积分10
36秒前
40秒前
涩费爱完成签到 ,获得积分10
41秒前
研友_n0kjPL完成签到,获得积分0
42秒前
忧伤的白秋完成签到,获得积分10
43秒前
fantasy的应助被369ninja采纳,获得10
46秒前
清洋完成签到 ,获得积分10
47秒前
渔渔完成签到 ,获得积分10
49秒前
49秒前
49秒前
Kamaru完成签到 ,获得积分10
50秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Hidden Empire of Finance: How Wall Street Profits from Our Cities and Fuels Global Inequality 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8166550
求助须知:如何正确求助?哪些是违规求助? 9559535
关于积分的说明 21750720
捐赠科研通 7757357
什么是DOI,文献DOI怎么找? 3429141
关于科研通互助平台的介绍 2553523
邀请新用户注册赠送积分活动 2473904